A new hospital room designed for older adults (Hospi'Senior).
Official title: Evaluation d'un Prototype de Chambre Innovante adaptée au Grand Age
Run by University Hospital, Angers · NCT06098534 · Data updated 2026-11-12
This will test whether staying in a new Hospi'Senior hospital room helps patients aged 75 and older leave the hospital sooner than a conventional room.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Hospital, Angers Government |
| Locations | 5 sites (Angers and 4 other locations) |
| Status | Recruiting |
| Started | November 9, 2023 |
| Main results expected | February 10, 2028 |
| Study ends | February 10, 2028 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT06098534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 75 or older admitted from the emergency department or directly from home to a short-stay geriatric unit who are placed in a single room and can consent or have an authorized representative.
✕Probably not a fit
Patients with planned admissions, those in double rooms, those hospitalized more than three days before enrollment, those with poor French comprehension, under legal protection, or with a medical contraindication are excluded and would not be expected to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Hospitals in Angers, Brest, and Nantes co-designed a prototype single room called Hospi'Senior aimed at improving care for elderly inpatients. Eligible patients aged 75 or older admitted to short-stay geriatric units are placed in either a Hospi'Senior room or a conventional single room and their outcomes are compared. The primary outcome is length of stay, with secondary outcomes including changes in functional ability, behavioral disorders, falls, pressure ulcers stage ≥2, and early rehospitalization measured during the stay and up to 30 days after discharge. Data are collected prospectively to determine whether the room design affects these clinical and safety outcomes.
Why it matters
Potential benefit: If successful, the Hospi'Senior room could shorten hospital stays and reduce complications such as falls, pressure ulcers, and early readmissions for older inpatients.
How similar studies have gone: Previous studies of hospital environment and room-design interventions for older adults have shown mixed but occasionally positive effects on falls and functional outcomes, so the approach is promising but not definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 75 years * Admission in a short-stay geriatric department following initial emergency care department or direct entry from home * Hospitalization in single room: Hospi'Senior or conventional * Affiliation to a social security scheme * Informed consent to participate in the study from the patient or his/her representative (tutor/curator if applicable, or in order of priority a trusted person, the family or a person with whom the person concerned has a close and stable relationship) Exclusion Criteria: * Contraindication to study participation at the discretion of the medical team * Hospitalization for more than 3 days (\>3 days) in the short-stay geriatric unit * Hospitalization in a double room * Planned hospitalization * Poor understanding of the French language * Patient under safeguard of justice
Where it's running
-
Angers University Hospital
Angers, France Recruiting -
Brest University Hospital
Brest, France Recruiting -
Nantes University Hospital
Nantes, France Recruiting -
Rennes University Hospital
Rennes, France Recruiting -
Tours University Hospital
Tours, France Recruiting
Study contacts
- Study coordinator: Olivier BRIERE, MD
- Email: olivier.briere@chu-angers.fr
- Phone: +33 2 41 35 47 25
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.